Skip to main content

Table 3 Calculated metabolic parameters at 5-year follow-up, based on OGTT and FSivGTT measures

From: Evolution of metabolic alterations 5 Years after early puberty in a cohort of girls predisposed to polycystic ovary syndrome

Conditions

Metabolic parameter

Calculated parameter

Controls (n = 8)

PCOSr (n = 8)

p

OGTT

Insulin sensitivity

ISIMatsuda

3.6 (2.4–7.3)

3.8 (2.6–6.0)

0.798

Insulin secretion

CIR30

1.1 (0.6–1.3)

1.2 (0.8–1.7)

0.574

β-cell function

DIOGTT

2.7 (2.3–4.7)

4.4 (4.1–6.1)

0.195

NEFA suppressibility

Logn-linear slope

−0.028 (−0.030 – −0.018)

−0.040 (−0.044 – −0.036)

<0.001

 

Logn-linear slope / AUCinsulin

−0.58 (−1.02 – −0.23)

−0.81 (−1.29 – −0.51)

0.195

 

T50NEFA (min)

40.6 (28.3–48.5)

34.1 (24.4–47.0)

0.645

FSivGTT

Insulin sensitivity

ISFSivGTT

3.4 (1.8–3.6)

3.2 (2.2–5.3)

0.878

Insulin secretion

AIRg

790 (343–813)

496 (361–997)

0.959

β-cell function

DIFSivGTT

1380 (1122–2563)

1926 (1376–2264)

0.442

NEFA suppressibility

Logn-linear slope

−0.032 (−0.040 – −0.024)

−0.032 (−0.088 – −0.018)

0.878

 

Logn-linear slope / AUCinsulin

−4.33 (−6.42 – −3.14)

−3.33 (−7.64 – −2.67)

0.505

 

T50NEFA (min)

20.8 (16.2–26.9)

18.1 (16.1–23.9)

0.574

  1. Values are expressed as median (25th–75th percentiles) and compared with Mann-Whitney test
  2. AIRg Acute insulin response to glucose, AUC Area under the curve, CIR30 Corrected insulin response at 30 min, FSivGTT Frequent sampling intra-venous glucose tolerance test, DI Glucose disposition index, DI OGTT ISIMatsuda × CIR30, DI FSivGTT ISFSivGTT × AIRg, IS FSivGTT Insulin sensitivity determined during the FSivGTT, ISI Insulin sensitivity index, Log n -linear slope Slope of Ln of NEFA concentrations (between time 0 to 20 min for the FSivGTT), Log n -linear slope /AUC Insulin Ratio of the Slope of Ln of NEFA concentrations to the area under the insulin curve ×1000 (between time 0 to 20 min for the FSivGTT), NEFA Non-esterified fatty acid, OGTT Oral glucose tolerance test, and T50 NEFA Time to suppress 50% of NEFA baseline levels